-
Yang Sheng meets with Danish ambassador and chairman of Novo Nordisk
2026-06-17
Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA), held talks with Michael Christensen, Denmark's ambassador to China, and Lars Sorensen, chairman of Danish global pharma group Novo Nordisk, on June 15 in Beijing.
-
Yang Sheng meets with Australian ambassador to China
2026-06-12
Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA), met with a delegation led by Scott Dewar, Australian ambassador to China, on June 4 in Beijing.
-
China updates drug clinical trial guideline to enhance biotech innovation
2026-06-12
China has recently released a new edition of the Good Clinical Practice for Drugs — a guideline designed to ensure the ethical and scientific conduct of clinical studies, aiming to enhance the nation's research ecosystem and support innovation in biotechnology.
-
Huang Guo meets with WHO representative to China
2026-06-01
Huang Guo, commissioner of the National Medical Products Administration (NMPA), met on May 27 in Beijing with a delegation led by Martin Taylor, World Health Organization (WHO) representative to China.
-
Huang Guo meets with Singaporean health authority CEO
2026-05-15
Huang Guo, commissioner of the National Medical Products Administration (NMPA), met in Beijing on May 11 with a delegation led by Raymond Chua Swee Boon, chief executive officer of the Health Sciences Authority (HSA) of Singapore.
-
NMPA holds special training program on quality improvement of vaccines, blood products
2026-04-17
On April 10, the National Medical Products Administration (NMPA) convened a special public training program, with online and on-site participation, on inspection, rectification and quality improvement of vaccines and blood products in order to further reinforce oversight of the quality and safety of these medical products.
